| Title |
Ibuprofen with or without an antiemetic for acute migraine headaches in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2013
|
| DOI | 10.1002/14651858.cd008039.pub3 |
| Pubmed ID | |
| Authors |
Roy Rabbie, Sheena Derry, R Andrew Moore |
| Abstract |
This is an updated version of the original review published in Issue 10, 2010 (Rabbie 2010). Migraine is a common, disabling condition and a burden for the individual, health services and society. Many sufferers do not seek professional help, relying instead on over-the-counter analgesics. Co-therapy with an antiemetic should help to reduce symptoms commonly associated with migraine headaches. |
Twitter Demographics
The data shown below were collected from the profiles of 24 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 21% |
| United States | 3 | 13% |
| United Kingdom | 3 | 13% |
| New Zealand | 1 | 4% |
| Australia | 1 | 4% |
| India | 1 | 4% |
| Fiji | 1 | 4% |
| Germany | 1 | 4% |
| Mexico | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 7 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 71% |
| Practitioners (doctors, other healthcare professionals) | 4 | 17% |
| Science communicators (journalists, bloggers, editors) | 2 | 8% |
| Scientists | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 139 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 27 | 19% |
| Student > Bachelor | 20 | 14% |
| Student > Ph. D. Student | 14 | 10% |
| Researcher | 6 | 4% |
| Student > Postgraduate | 6 | 4% |
| Other | 15 | 11% |
| Unknown | 53 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 41 | 29% |
| Psychology | 11 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 7% |
| Nursing and Health Professions | 8 | 6% |
| Neuroscience | 6 | 4% |
| Other | 12 | 9% |
| Unknown | 53 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2022.
All research outputs
#1,294,560
of 24,396,012 outputs
Outputs from Cochrane database of systematic reviews
#2,854
of 12,903 outputs
Outputs of similar age
#10,125
of 195,511 outputs
Outputs of similar age from Cochrane database of systematic reviews
#53
of 263 outputs
Altmetric has tracked 24,396,012 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,903 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.2. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,511 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 263 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.